nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alternative Dosing Schedules for Cetuximab: A Role for Biweekly Administration?
|
Ramanathan, Ramesh K. |
|
2008 |
|
6 |
p. 364-368 5 p. |
artikel |
2 |
A Molecular/Epidemiologic Analysis of Expression of Cyclooxygenases 1 and 2,Use of Nonsteroidal Antiinflammatory Drugs, and Risk of Colorectal Adenoma
|
Haile, Robert W. |
|
2005 |
|
6 |
p. 390-395 6 p. |
artikel |
3 |
Collision Tumor of the Large Bowel in the Context of Advanced Pregnancy and Ulcerative Colitis
|
Duffy, Austin |
|
2008 |
|
6 |
p. 402-405 4 p. |
artikel |
4 |
Colorectal Cancer Awareness Month – 2007
|
Chu, Edward |
|
2007 |
|
6 |
p. 406- 1 p. |
artikel |
5 |
Colorectal Cancer Awareness Month
|
Chu, Edward |
|
2006 |
|
6 |
p. 389- 1 p. |
artikel |
6 |
Colorectal Cancer Treatment in Elderly Patients: An Update on Recent Clinical Studies
|
Merlin, Federica |
|
2008 |
|
6 |
p. 357-363 7 p. |
artikel |
7 |
Diagnosis and Management of Cancer Treatment–Induced Diarrhea
|
Wadler, Scott |
|
2005 |
|
6 |
p. 382-383 2 p. |
artikel |
8 |
Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience
|
Gebbia, Vittorio |
|
2006 |
|
6 |
p. 422-428 7 p. |
artikel |
9 |
Equal Opportunity for the Elderly
|
Chu, Edward |
|
2008 |
|
6 |
p. 356- 1 p. |
artikel |
10 |
Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007
|
Bertino (Moderator), Joseph |
|
2007 |
|
6 |
p. 407-422 16 p. |
artikel |
11 |
Highlights From: The American Society of Clinical Oncology Gastrointestinal Cancers Symposium; Hollywood, FL January 2005
|
Reddy, G. Kesava |
|
2005 |
|
6 |
p. 367-374 8 p. |
artikel |
12 |
Highlights From: The 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006
|
Gibson, Tara Beers |
|
2006 |
|
6 |
p. 398-402 5 p. |
artikel |
13 |
Hypoxia-Induced Lactate Dehydrogenase Expression and Tumor Angiogenesis
|
Colgan, Stephen M. |
|
2007 |
|
6 |
p. 442-446 5 p. |
artikel |
14 |
Local Excision for Rectal Carcinoma
|
Kim, Edward |
|
2008 |
|
6 |
p. 376-385 10 p. |
artikel |
15 |
Mitomycin-C/5-Fluorouracil/Leucovorin and Hyperfractionated Radiation Therapy for Rectal Carcinoma: A Phase II Study with Long-Term Follow-up
|
Nabhan, Chadi |
|
2007 |
|
6 |
p. 436-441 6 p. |
artikel |
16 |
Multicenter Phase II Study of Fixed Sequences of Capecitabine Combined with Oxaliplatin or Irinotecan in Patients with Previously Untreated Metastatic Colorectal Cancer
|
Cassinello, Javier |
|
2006 |
|
6 |
p. 429-435 7 p. |
artikel |
17 |
Neoadjuvant Treatment of Unresectable Liver Metastases from Colorectal Cancer
|
Chua, Yu Jo |
|
2006 |
|
6 |
p. 405-412 8 p. |
artikel |
18 |
New Developments at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
|
Chu, Edward |
|
2005 |
|
6 |
p. 358-359 2 p. |
artikel |
19 |
Panitumumab with Irinotecan/Leucovorin/5-Fluorouracil for First-Line Treatment of Metastatic Colorectal Cancer
|
Berlin, Jordan |
|
2007 |
|
6 |
p. 427-432 6 p. |
artikel |
20 |
Predictive Value of MSH2 Gene Expression in Colorectal Cancer Treated with Capecitabine
|
Jensen, Lars H. |
|
2007 |
|
6 |
p. 433-435 3 p. |
artikel |
21 |
Prognostic Significance of Increasing Lymph Node Count in Stage III Colorectal Cancer
|
Reddy, G. Kesava |
|
2006 |
|
6 |
p. 403-404 2 p. |
artikel |
22 |
Proteomic Approaches in Colon Cancer: Promising Tools for New Cancer Markers and Drug Target Discovery
|
Alessandro, Riccardo |
|
2005 |
|
6 |
p. 396-402 7 p. |
artikel |
23 |
Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer
|
Cartwright, Thomas |
|
2008 |
|
6 |
p. 390-397 8 p. |
artikel |
24 |
Reversible Grade 4 Hyperbilirubinemia in a Patient with UGT1A1 7/7 Genotype Treated with Irinotecan and Cetuximab
|
Gupta, Bhavna |
|
2007 |
|
6 |
p. 447-449 3 p. |
artikel |
25 |
Role of Combined-Modality Therapy in the Management of Locally Advanced Rectal Cancer
|
Hosein, Peter J. |
|
2008 |
|
6 |
p. 369-375 7 p. |
artikel |
26 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2007 |
|
6 |
p. 450- 1 p. |
artikel |
27 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2006 |
|
6 |
p. 439- 1 p. |
artikel |
28 |
Southwest Oncology Group 0408: Phase II Trial of Neoadjuvant Capecitabine/Oxaliplatin/Bevacizumab for Resectable Colorectal Metastases in the Liver
|
Abdalla, Eddie K. |
|
2006 |
|
6 |
p. 436-438 3 p. |
artikel |
29 |
Surgical Resection of a Solitary Pancreatic Metastasis from Colorectal Cancer: A New Step to a Cure?
|
Grevelos, Cristina |
|
2008 |
|
6 |
p. 398-401 4 p. |
artikel |
30 |
Ten-Year Results of Preoperative Radiation Followed by Sphincter Preservation for Rectal Cancer: Increased Local Failure Rate in Nonresponders
|
Rengan, Ramesh |
|
2006 |
|
6 |
p. 413-421 9 p. |
artikel |
31 |
The Assessment and Management of Cancer Treatment–Related Diarrhea
|
O'Brien, Bridget E. |
|
2005 |
|
6 |
p. 375-381 7 p. |
artikel |
32 |
Trends in Chemotherapy Utilization for Colorectal Cancer
|
Renouf, Daniel |
|
2008 |
|
6 |
p. 386-389 4 p. |
artikel |
33 |
Two Consecutive Phase II Trials of Biweekly Oxaliplatin plus Weekly 48-Hour Continuous Infusion of Nonmodulated High-Dose 5-Fluorouracil as First-Line Treatment for Advanced Colorectal Cancer
|
Abad, Albert |
|
2005 |
|
6 |
p. 384-389 6 p. |
artikel |